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Abstract
Background:  Among  the  rarest  types  of  cancer  found  are  the  small  intestine  malignancies,  rep-
resenting only  2%  of  all  gastrointestinal  cancer  and  0.1--0.3%  of  all  malignancies.  The  most
common  subtype  of  this  tumour  is  the  adenocarcinoma,  which  is  located  mainly  in  the  duode-
num, jejunum  and,  rarely,  in  ileum.
Clinical  case:  A  75-year-old  male,  with  no  surgical  history,  who  in  the  previous  three  months,
referred  to  two  clinical  episodes  of  partial  bowel  obstruction  and  unquantiﬁed  weight  loss.
When admitted  into  the  surgical  service,  the  patient  referred  to  a  partial  bowel  obstruction
of more  than  one-week  onset.  A  laparotomy  was  performed,  ﬁnding  three  stenosis  rings  at  the
ileum end  portion,  carrying  out  an  intestinal  resection  and  enteral-enteral  anastomosis.  On  the
seventh day  there  was  dehiscence  of  the  anastomosis  and  abdominal  sepsis.  New  surgery  was
performed  with  the  resection  of  the  intestinal  anastomosis  and  an  ileostomy.  The  pathologist
report indicated  a  small  bowel  adenocarcinoma  moderately  differentiated,  ulcerated,  and  mul-
tifocal. It  was  classiﬁed  as  stage  III  or  T3N1M0.  The  patient  progress  was  satisfactorily  managed
as outpatient  with  postoperative  chemotherapy  with  ﬁve  ﬂuorouracil  and  cisplatin.  The  patient
died a  year  later  due  to  liver  metastases.
Conclusions:  Due  to  the  extreme  rarity  of  the  case,  it  is  very  likely  that  general  surgeons  may
ﬁnd one  or  two  cases  of  adenocarcinoma  of  the  ileum  in  their  professional  career.  Thus,  they
must suspect  this  pathology  when  faced  with  an  episode  of  intestinal  obstruction  in  the  adult.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
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Resumen
Antecedentes:  Entre  los  tipos  de  cáncer  poco  frecuentes  encontramos  las  neoplasias  malignas
de intestino  delgado,  que  representan  el  2%  de  todas  las  neoplasias  del  sistema  gastrointesti-
nal y  el  0.1--0.3%  de  todas  las  neoplasias  malignas.  De  estas,  el  subtipo  más  frecuente  es  el
adenocarcinoma,  con  su  principal  localización  en  duodeno,  yeyuno  y,  con  menor  frecuencia,  en
íleon.
Caso clínico:  Varón  de  75  an˜os  de  edad  sin  antecedentes  quirúrgicos,  quien  reﬁere  en  los  3
meses previos  haber  presentado  2  cuadros  de  suboclusión  intestinal  y  pérdida  ponderal  no
cuantiﬁcada.  A  su  ingreso  al  servicio  de  Cirugía  muestra  suboclusión  intestinal  de  una  semana
de evolución.  Se  realizó  laparotomía  exploradora,  mediante  la  cual  se  localizaron  3  estenosis
anulares  en  íleon  terminal;  se  realizó  resección  intestinal  con  entero-entero  anastomosis.  Al
séptimo día  se  presentó  dehiscencia  de  la  anastomosis  con  sepsis  abdominal,  por  lo  que  se
efectuó una  nueva  cirugía  con  resección  de  la  anastomosis  intestinal  e  ileostomía.  El  estudio
de anatomía  patología  reportó  adenocarcinoma  de  intestino  delgado  moderadamente  diferen-
ciado, ulcerado  y  multicéntrico.  Clasiﬁcación:  estadio  III  o  T3N1M0.  El  paciente  presentó  una
evolución  satisfactoria  y  se  decidió  su  manejo  ambulatorio  con  quimioterapia  postoperatoria
con 5-ﬂuorouracilo  y  cisplatino.  Fallece  al  an˜o  de  postoperado  por  metástasis  hepáticas.
Conclusiones:  Por  la  rareza  del  caso,  es  probable  que  los  cirujanos  generales  atiendan  en  su  vida
quirúrgica uno  o  2  casos  de  adenocarcinoma  de  íleon,  por  lo  tanto,  siempre  que  se  enfrenten  a
un cuadro  de  suboclusión  intestinal  en  el  adulto  deben  sospechar  esta  dolencia.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Among  the  rare  types  of  cancers  are  malignant  neoplasms
of  the  small  intestine.  Although  these  account  for  75%  of
all  the  digestive  tract  and  90%  of  the  mucous  surface,  these
neoplasms  only  occur  in  2%  of  all  carcinomas  of  the  gas-
trointestinal  system,  thus  accounting  for  0.1--0.3%  of  all
malignant  neoplasms.1--4 In  the  United  States,  these  account
for  0.46%  of  all  malignancies  of  the  small  intestine,  while  in
South  Korea  they  account  for  0.35%.5 These  tumours  more
commonly  occur  during  the  sixties  and  more  frequently  in
male  patients,  without  any  marked  differences  regarding
gender.6--9
Of  these  neoplasms,  the  most  frequent  subtype  is  the
adenocarcinoma,  which  accounts  for  40--50%  of  the  cases.
It  is  mainly  located  in  the  duodenum  and  jejuno,  and  it
is  rarely  located  in  the  ileum.4,10 It  appears  as  an  annular,
nodular  or  ulcerated  strenuous  lesion,  irregular  and  eccen-
tric,  with  prominent  borders  that  are  abruptly  continued  in
the  mucosa,  which  may  cause  partial  intestinal  obstruction.
It  is  frequently  located  near  Vater’s  ampulla,  so  it  may  begin
with  obstructive  jaundice.9
The  presence  of  multiple  primary  tumours  in  a  patient
is  currently  a  very  commonly  diagnosed  clinical  condition.
Therefore,  multiple  primary  tumours  refer  to  neoplasms
present  in  a  subject  in  a  simultaneous  or  consecutive  man-
ner,  provided  they  meet  the  following  criteria:  (1)  each
tumour  must  have  a  deﬁned  malignancy  pattern;  (2)  rule
out  the  possibility  of  it  metastasising  from  another  tumour;
(3)  each  tumour  should  have  a  different  histology;  if  both
are  similar  within  the  same  organ,  it  must  be  demonstrated
that  there  is  no  connection  between  them;  (4)  each  tumour
p
oust  follow  its  natural  course;  (5)  they  may  have  indepen-
ent  progressions;  and  (6)  if  their  diagnosis  is  simultaneous
r  if  it  is  made  within  the  ﬁrst  6  months,  they  are  consid-
red  synchronous;  if  their  diagnosis  is  consecutive,  they  are
onsidered  metachronous.  A  little  more  than  37%  are  mul-
icentric  tumours  occurring  in  the  same  organ.  Multifocality
s  deﬁned  as  the  presence  of  two  or  more  tumour  foci  in  the
ame  area,  located  less  than  5  cm  from  the  primary  focus,
hile  multicentricity  is  the  presence  of  two  or  more  tumour
oci  in  different  sites,  located  more  than  5  cm  from  the  pri-
ary  focus.10,11 However,  synchronous  primary  tumours  are
ot  very  frequent.11
The  primary  adenocarcinoma  of  the  small  intestine
ocated  in  the  terminal  ileum  represents  a  challenge,
iven  its  rare  nature.  It  is  associated  with  a  non-speciﬁc
ymptomatology  and  with  its  location,  which  hinders  its
isualisation  by  conventional  endoscopy.  This  delays  its
imely  diagnosis  and  treatment,  which  leads  to  a  poor
rognosis.1--3,5,10--14 Frequently,  these  tumours  are  detected
n  emergency  surgeries  conducted  due  to  complications  of
he  tumour  itself,  such  as  intestinal  obstruction,  perforation
nd  haemorrhaging.14
The  symptomatology  is  scarce  and  non-speciﬁc  in  the  ini-
ial  stages  of  the  disease  and  mainly  involves  gastrointestinal
ymptoms  (nausea,  vomiting  and  postprandial  fullness).
his  is  due  to  its  anatomy,  given  that  the  small  intestine
s  difﬁcult  to  examine.  The  most  important  symptoms  in
hese  cases  involve  weight  loss,  abdominal  pain  (52%  of
atients)  and  intestinal  occlusion  or  subocclusion  (36%  of
atients).13
Nevertheless,  there  are  now  more  speciﬁc  studies  to
btain  a  diagnosis  in  earlier  stages.14 A  clear  relation
2 R.F.  Candia-de  la  Rosa  et  al.
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etween  the  increase  in  tumour  markers  and  the  adenocar-
inoma  of  the  small  intestine  has  not  yet  been  established.2
ases  of  an  increase  in  the  CA19-9  marker  and  carcinoem-
rionary  antigen  have  been  reported,  although  this  increase
as  not  yet  been  associated  with  the  prognosis.  However,
n  association  between  the  increase  in  the  CA19-9  marker
nd  the  tumour  invasion  of  the  peritoneum  does  exist.2 The
ntestinal  disease  analysis  is  still  based  on  radiology,  and
ntestinal  transit  method  is  one  of  the  most  commonly  used
ethods.  Other  promising  studies  include  the  Doppler  ultra-
ound  with  intravenous  contrast  material,  which  reveals
he  lesion  blood  supply,  distribution  and  structure.15 The
omputed  tomographic  enteroclysis  is  a  helical  procedure
ith  multiple  detectors  that  allows  for  an  adequate  disten-
ion  and  visibility  of  the  small  intestine.15 The  endoscopic
apsule  overrides  the  disadvantages  of  the  conventional
ndoscopy  and  explores  almost  the  entire  small  intestine
ithout  insufﬂation.  This  considerably  improves  the  diagno-
is  and  visibility  of  lesions  and  also  conﬁrms  the  diagnosis  in
atients  who  have  previously  undergone  conventional  radio-
ogical  studies  which  revealed  apparently  normal  results.
he  double-balloon  enteroscopy  allows  for  the  assessment
f  the  small  intestine  through  an  antegrade  and  retrograde
xam,  which  results  in  visibility  of  the  entire  intestine.16--18
For  its  treatment,  an  open  examination  and  a  laparoscopy
re  ideal  options  for  the  surgical  management  when  surgery
s  mandatory,  such  as  in  patients  with  full  intestinal  occlu-
ion,  with  signs  or  symptoms  that  indicate  strangulation
r  perforation,  or  in  patients  with  unresolved  subocclusion
4  or  48  h  following  non-surgical  medical  treatment.4 On
iagnosis,  almost  40%  of  tumours  are  irresectable  due  to
heir  metastases,  thus  reducing  the  surgical  curative  per-
entage  to  67%  of  the  total  cases,  and  surgery  is  simply
alliative  in  the  remaining  cases.2 Occlusion  in  the  cases  of
rimary  or  secondary  carcinomas  is  not  resolved  by  imple-
enting  a  conservative  treatment,  and  surgical  intervention
s  always  indicated.4 The  objective  of  the  surgical  treatment
f  small  intestine  cancer  is  its  broad  resection,  including
egional  lymph  nodes,  with  potentially  curative  intention.
n  stage  III  cancers,  if  the  lesion  is  located  near  the  ileoce-
al  valve,  a  laparoscopically  assisted  right  hemicolectomy  is
ecommended,  with  full  resection  of  the  tumour  through  a
ymphadenectomy,  so  as  to  avoid  recurrence  or  metastases.
his  objective  has  an  impact  on  the  prognosis,  but  not  all
atients  will  have  a  considerable  life  expectancy.19
The  effectiveness  of  chemotherapy  and  radiothe-
apy  has  not  yet  been  demonstrated.  Nevertheless,  in
dvanced-stage  patients,  with  inoperable  metastases  or
denocarcinoma,  these  techniques  improve  life  expectancy.
here  is  not  much  experience  with  adenocarcinomas.
hemotherapy  treatments  are  used  with  other  tumours,
uch  as  colon  cancers,  such  as  5-ﬂuorouracil  combined
ith  leucovorin,  irinotecan  and  oxaliplatin,  as  well  as
rganoplatin  agents,  tyrosine  kinase  inhibitors  (imatinib
esylate)  or  multikinase  inhibitors  (sunitinib).1--3,5--17,20--24
ecent  studies  show  a  capecitabine-based  regime  combined
ith  oxaliplatin  to  improve  treatment  response  and  obtain  a
onger  life  expectancy  in  advanced-stage  patients.25 Several
etrospective  studies  have  assessed  adjuvant  chemoradia-
ion  therapy  followed  by  adenocarcinoma  resection,  but  it
as  not  yet  been  demonstrated  that  adjuvant  treatment  pro-
ides  a  beneﬁt.  However,  it  may  be  used  as  a  palliative
w
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wigure  1  Simple  abdominal  X-ray  showing  intestinal  disten-
ion without  hydro-aerial  levels  and  distal  air  in  the  rectum.
reatment  for  pain  or  obstructive  symptoms.  It  has  also  been
bserved  that  it  offers  beneﬁts  for  the  control  of  chronic
lood  loss  related  to  the  tumour.
linical case
 75-year-old  male  patient  with  two  symptoms  of  intestinal
ubocclusion  and  non-quantiﬁed  weight  loss  3  months  before
is  admission.  When  admitted  to  the  Surgery  Department,
e  presented  one-week  progression  abdominal  pain  in  the
orm  of  intense  colics,  and  vomiting  with  food  content,  who
enied  having  obstipation  but  did  conﬁrm  the  presence  of
onstipation.  After  conducting  a  physical  examination,  the
ollowing  ﬁndings  were  obtained:  thin,  non-icteric,  regularly
ydrated  patient.  Vital  signs:  blood  pressure:  110/80  mmHg;
ulse:  86  bpm,  respiration:  20  rpm;  temperature:  36.5 ◦C;
eight:  64  kg;  stature:  1.64  m.  Neck  with  positive  jugular
ngurgitation.  Distended  abdomen,  with  generalised  tym-
anism,  pain  on  superﬁcial  and  deep  palpation,  without
ecompression  pain,  hydro-aerial  noises,  without  megalia.
ab  results  upon  admission  were  as  follows:  glucose
22  mg/dl;  urea  57  mg/dl;  creatinine  1.1  mg/dl;  blood  urea
itrogen  (BUN)  26.6  mg/dl;  total  cholesterol  153  mg/dl;
riglycerides  237  mg/dl;  haemoglobin  9.2  g/dl;  haematocrit
7%;  leukocytes  10,500;  neutrophils  88%;  lymphocytes  9%;
egmented  neutrophils  78%;  platelets  716,000;  total  biliru-
in  0.93  mg/dl;  indirect  bilirubin  0.70  mg/dl;  direct  bilirubin
.23  mg/dl;  oxaloacetic  glutamic  transaminase  50  U/l;  pyru-
ic  glutamic  transaminase  56  U/l;  alkaline  phosphatase
47  U/l;  total  proteins  7  g/dl;  serum  albumin  4.6  g/dl;
lbumin-globulin  ratio  1.9  g/dl;  the  general  urine  test  was
ormal.  Carcinoembrionary  antigen  4.81  ng/dl;  prostatic
ntigen  1.9  ng/dl;  alpha  fetoprotein  2.8  ng/ml.  The  simple
bdominal  X-ray  showed  an  image  of  intestinal  occlusion
ith  distended  small  intestinal  loops  and  hydro-aerial  levels,
ith  air  in  the  rectum  ampulla  (Fig.  1).
The  patient  was  diagnosed  with  paraneoplastic  syndrome
ith  symptoms  of  intestinal  occlusion.
Primary  adenocarcinoma  of  the  terminal  ileum,  synchronous  
Figure  2  Annular  stenosis  in  the  ileum,  at  70  cm  from  the
ileocecal  valve.
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aFigure  3  Macroscopic  cut  of  annular  adenocarcinoma  tumour
in the  ileum  and  ulceration.
The  colon  X-ray  through  an  enema  was  reported  as
normal.  The  abdominal  ultrasound  showed  a  normal  liver,
without  presence  of  metastasis,  with  considerable  intesti-
nal  distension  and  no  indication  of  the  cause  of  the  intestinal
obstruction.
Medical  care  was  provided  during  48  hours,  without
any  improvement  in  the  intestinal  subocclusion  syndromes.
Therefore,  the  ﬁrst  surgical  team  decided  to  perform  an
exploratory  laparotomy.  Upon  examining  the  small  intes-
tine,  three  annular  stenoses  were  found  in  the  terminal
ileum  (Fig.  2),  at  40,  70  and  100  cm  from  the  ileocecal
valve,  respectively,  with  ﬁndings  of  unclear  and  non-foetid
serohaematic  free  ﬂuid,  without  palpable  lymph  nodes  and
liver  without  metastasis.  After  the  collection  of  these  ﬁnd-
ings,  the  following  procedures  were  performed:  an  en-block
intestinal  resection  of  the  three  stenoses,  termino-terminal
anastomosis  of  the  intestine  at  20  cm  from  the  ileocecal
valve,  and  placement  of  two  Penrose-type  drains.  In  the
macroscopic  cut  of  one  of  the  stenoses,  tissue  with  ﬁsh-
meat  characteristics  was  observed  in  the  mesenteric  border
(Fig.  3).  One  week  after  the  surgical  intervention,  there  was
biliary  output  due  to  the  Penrose  drain,  so  a  new  exploratory
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aparotomy  was  performed  by  our  surgical  team.  In  this  case,
he  anastomosis  microscopic  dehiscence  was  located,  with
resence  of  localised  peritonitis.  Thus,  the  anastomosis  was
esected,  the  terminal  ileum  was  closed  with  Hartmann’s
ouch,  and  an  ileostomy  was  performed.
The  histopathological  study  revealed  the  following:
oderately  differentiated  adenocarcinoma  of  the  small
ntestine,  ulcerated,  multifocal,  peritumoural  adipose  tis-
ue  inﬁltration,  with  tumour-free  surgical  limits,  22
eritumoural  lymph  nodes  with  sinusoidal  hyperplasia  and
wo  with  tumoural  activity.  Thus,  the  patient  was  diagnosed
ith  adenocarcinoma  of  the  small  intestine,  with  presence
f  omental  metastasis  (Fig.  4).  The  cancer  staging  was  stage
II  or  T3N1M0.  During  the  following  10  days,  the  patient
as  treated  with  oxygen  therapy,  antibiotics  therapy,  par-
nteral  ﬂuids  and  parenteral  nutrition.  He  was  discharged
7  days  after  his  admission  and  continued  with  ambula-
ory  treatment  in  the  Medical  Oncology  Department  using
-ﬂuorouracil  and  cisplatin.  The  patient  died  one  year  later
ue  to  hepatic  metastases.
iscussion
t  is  very  common  for  general  surgeons  to  provide  treat-
ent  by  primary  intention  to  patients  with  symptoms  of
ntestinal  subocclusion  or  occlusion,  and,  although  these  are
are,  gastrointestinal  carcinomas  are  generally  detected  in
ery  advanced  stages,  as  shown  in  this  case.4 The  following
ncological  principles  must  always  be  taken  into  account  to
rovide  a  better  life  expectancy  to  patients:  (1)  order  a  tran-
operative  histopathological  study;  (2)  request  support  from
n  oncological  surgeon  if  the  presence  of  a  neoplasm  is  con-
rmed;  and  (3)  request  an  examination  of  tumour  markers,
hich  are  necessary  for  patients’  follow-up.
In  the  case  of  terminal  ileum  adenocarcinoma  neoplasms,
he  age  and  gender  of  patients  must  be  taken  into  account,
iven  that  there  is  a  higher  distribution  in  male  patients
lder  than  sixty  years  old.6--9 The  ileum  is  a very  rare  loca-
ion,  and  the  symptomatology  is  non-speciﬁc,  but  weight
oss  is  a  pathognomonic  sign  of  tumour  disease.  In  this  case,
he  surgical  management  was  performed  without  oncologi-
al  criteria,  given  its  non-speciﬁc  initial  symptoms,  which
ncluded  the  following:  three  symptoms  of  intestinal  sub-
cclusion  and  weight  loss  (which  was  not  quantiﬁed  for
his  case).  The  manifestation  of  the  lesion  for  this  case
oincides  with  that  described  in  the  medical  literature,  as
t  appears  as  an  annular,  ulcerated  and  irregular  strenu-
us  lesion,  continued  in  the  mucosa,  which  caused  partial
ntestinal  obstruction  symptoms.  The  exceptional  presenta-
ion  of  the  case  is  the  primary  and  synchronous  existence  of
hree  tumours  at  30,  70  and  100  cm  from  the  ileocecal  valve.
he  above-mentioned  risk  factors  for  the  development  of
ntestinal  neoplasms  include:  Crohn’s  disease,  familial  ade-
omatous  polyposis,  coeliac  disease,  type  II  Lynch  syndrome,
eutz-Jeghers  syndrome,  peptic  ulcer,  cystic  ﬁbrosis  and
chistosomiasis  japonicum.4,20,21 In  some  patients,  there  was
n  increase  in  the  CA19-9  antigen  or  carcinoembrionary
ntigen;  in  our  patient,  we  ordered  a  test  for  the  carcinoem-
rionary  antigen,  which  showed  a  normal  result,  while  a
A19-9  antigen  test  to  supplement  the  diagnosis  and  follow-
p  is  yet  to  be  ordered.  To  analyse  the  small  intestine
236  R.F.  Candia-de  la  Rosa  et  al.
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isease  using  radiology,  simple  abdominal  X-ray  tests  were
erformed  in  this  case,  which  provided  intestinal  occlusive
ata  with  no  other  relevant  sign.  The  contrast  study  and
ltrasound  reported  no  apparent  or  metastatic  changes.  On
uspicion  of  paraneoplastic  symptoms,  the  surgical  mana-
ement  was  chosen,  since  it  is  the  recommended  approach
hen  there  is  no  improvement  using  medical  management.4
ased  on  the  ﬁndings,  the  transurgical  objective  was  broad
esection,  including  regional  lymph  nodes,  with  potentially
umour  curative  intention.  In  stage  III,  as  shown  in  this  case,
nd  given  that  the  tumour  was  close  to  the  ileocecal  valve,
 laparoscopically  assisted  right  hemicolectomy  was  recom-
ended,  with  full  resection  of  the  tumour  through  a  lym-
hadenectomy,  so  as  to  avoid  recurrence  or  metastatses.19
he  complication  arising  from  intra-abdominal  sepsis  due
o  dehiscence  in  the  entero  anastomosis  was  resolved  with
n  ileostomy  (This  is  an  expected  complication  due  to  mal-
utrition  in  this  type  of  patient).  Due  to  its  presentation,
he  chances  of  hepatic  metastases  were  higher.  Thus,  the
urgery  performed  had  to  be  more  radical.  Our  Medical
ncology  Department  used  a  5-ﬂuorouracil  and  cisplatin
cheme,  thus  achieving  a  one-year  life  expectancy,  and  the
ause  of  death  was  hepatic  metastases.  Other  retrospec-
ive  studies  have  assessed  the  adjuvant  chemoradiation  with
esection  of  the  duodenum  adenocarcinoma  without  yet
howing  any  beneﬁts,  except  for  the  palliative  treatment
f  pain  and  obstructive  symptoms.
The  prognosis  for  these  patients  is  correlated  with  age,
umour  site,  clinical  stage,  lymph  node  metastases,  perfor-
ance  of  surgical  resection  and  positive  surgical  margins.
egative  surgical  margins  after  surgery  improve  the  progno-
is.
It  was  decided  to  publish  this  case  due  to  the  low  fre-
uency  with  which  this  disease  occurs  and  the  lack  of
eferences  in  the  national  bibliography.
onclusion
he  adenocarcinoma  of  the  small  intestine  is  a  rarely
ccurring  malignant  neoplasm.  It  is  mainly  located  in  the
uodenum  and  jejuno,  and  less  frequently  located  in  the
leum,  and  multiple  synchronous  or  metachronous  tumours
an  be  found.  Because  of  the  low  frequency  of  the  case,inoma.  Haematoxylin--eosin  staining.
t  is  very  likely  that  active  general  surgeons  may  treat  only
ne  or  two  cases  of  ileum  adenocarcinoma  in  their  surgical
ife.  Therefore,  on  symptoms  of  partial  intestinal  obstruc-
ion  in  an  adult,  this  condition  must  be  suspected.  Likewise,
t  is  important  to  refer  these  patients  to  a  surgical  oncol-
gist  with  more  experience  in  such  a  condition  to  avoid
ncomplete  surgeries  and  achieve  a better  life  expectancy.
An  examination  of  the  entire  small  intestine  should  also
e  performed  during  surgery  in  case  there  is  more  than  one
umour.
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